# Nicolas Vachicouras

> Nicolas Vachicouras is the Swiss engineer, scientist, and CEO who co-founded Neurosoft Bioelectronics to translate soft, stretchable neural interfaces from EPFL research into scalable brain-computer interface technology. After shaping his studies around neuroprosthetics, he built a team with longtime collaborators, advanced the platform into human studies, established a New York presence, and is now pairing cortical data with NeuroAI models.

- **Role:** CEO & Co-Founder at Neurosoft Bioelectronics
- **Organizations:** Neurosoft Bioelectronics, EPFL, Center for Neuroprosthetics, Aleva Neurotherapeutics, Massachusetts Eye and Ear / Harvard Medical School
- **Nationality:** Swiss
- **Education:** PhD, Microsystems and Microelectronics; thesis on soft microfabricated neural implants, EPFL (École polytechnique fédérale de Lausanne), MSc, Microengineering (Micro & Nanosystems), minor in Biomedical Engineering, EPFL (École polytechnique fédérale de Lausanne), BSc, Microengineering, EPFL (École polytechnique fédérale de Lausanne), Bilingual French-English Maturity Diploma, Collège André-Chavannes
- **Known for:** Co-founded Neurosoft Bioelectronics, an EPFL spin-off developing soft, stretchable brain-computer interfaces., Authored a 2019 EPFL doctoral thesis titled 'Soft microfabricated neural implants: a path towards translational implementation.', Won the 2019 IMAGINE IF! Lausanne competition and audience prize with the Neurosoft team.

## Career timeline

- **2009** — Began microengineering studies at EPFL with the stated goal of engineering medical devices.
- **2012-2014** — Focused his master's work on micro- and nanosystems and biomedical engineering, including neural-interface research and a thesis placement at Massachusetts Eye and Ear / Harvard Medical School.
- **2015-2019** — Completed doctoral work at EPFL on soft microfabricated neural implants under Prof. Stéphanie Lacour.
- **2018** — Pitched the emerging Neurosoft technology at the European Venture Programme Pitch Battle.
- **2019** — Completed his PhD and, with the Neurosoft team, won the IMAGINE IF! Lausanne competition and audience prize.
- **2020** — Neurosoft Bioelectronics was incorporated as an EPFL spin-off; Vachicouras became CEO and co-founder.
- **2023** — Neurosoft announced first-in-human recordings using its soft electrode technology in three surgical cases at UTHealth Houston and Memorial Hermann.
- **2025** — The company reported human testing of a 256-electrode soft, stretchable brain interface and added two NeuroAI scientific advisors.
- **2026** — Neurosoft partnered with Science Corp, expanded its New York presence, raised a $7.5 million oversubscribed round, and appointed a VP of NeuroAI.

## Achievements

- Co-founded Neurosoft Bioelectronics, an EPFL spin-off developing soft, stretchable brain-computer interfaces.
- Authored a 2019 EPFL doctoral thesis titled 'Soft microfabricated neural implants: a path towards translational implementation.'
- Won the 2019 IMAGINE IF! Lausanne competition and audience prize with the Neurosoft team.
- Helped advance Neurosoft interfaces from academic research to first-in-human recordings announced in 2023.
- Led Neurosoft through a 2026 oversubscribed $7.5 million financing round, bringing reported total funding above $20 million.
- Built a transatlantic company presence spanning Geneva and New York.

## Latest updates

- **2026-07** — Neurosoft appointed Sam Hosovsky as Vice President of NeuroAI to lead its neural-data and cortical foundation-model strategy.
- **2026-07** — Vachicouras appeared on The Business of Neurotech podcast to discuss BCI hardware trade-offs, startup building, fundraising, and Neurosoft's partnership with Science Corp.
- **2026-05** — Neurosoft closed a $7.5 million oversubscribed financing round to advance minimally invasive deployment, US commercialization, and cortical foundation-model development.
- **2026-02** — Neurosoft and Science Corp announced a partnership around clinical-grade neural recording technology.
- **2026-01** — Neurosoft established a second office in New York to support its US clinical, regulatory, funding, and ecosystem strategy.

## Links

- Website: https://www.neurosoft-bio.com
- LinkedIn: https://www.linkedin.com/in/nicolas-vachicouras-360b9860

---

Profile page: https://yespress.io/nicolas-vachicouras
Published by YesPress — https://yespress.io
Last updated: 2026-08-27